Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study

Journal:
The Lancet Oncology
Published:
Affiliations:
5
Authors:
11
Institutions Authors Share
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
10.333333
10.333333
0.94
Hangzhou Institute of Medicine (HIM), CAS, China
0.333333
0.03
Zhejiang Cancer Hospital (ZJCH), China
0.333333
0.03